Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1026706 in Male and Female Healthy Subjects and Patients With Osteoarthritis of the Knee [Phase 1]

View source ↗

Summary

Phase 1 study assessing safety, tolerability, pharmacokinetics and pharmacodynamics of rising oral doses of BI 1026706 in healthy subjects and osteoarthritis of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• BI 1026706 (BI 1026706)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Osteoarthritis | Phase 1 | Status: COMPLETED | Results posted: 2019-03-25